FTC Sues to Block Acquisition of Exclusive Drug License

The deal would give the French company a pharmaceutical monopoly over Pompe Disease therapy. The Federal Trade Commission (FTC) has taken action to prevent Sanofi from acquiring an…

Read More

Senator Sanders Plans to Work with New NIH Director

The senator believes fair pricing can be built into federal contracts with pharmaceutical companies. Senator Bernie Sanders of Vermont plans to work with the new director of the…

Read More

FDA Approves New Treatment for Rare Blood Clotting Disorder

Director Marks announced the therapy for the life-threatening disorder. The U.S. Food and Drug Administration recently approved Adzynma for patients with congenital thrombotic thrombocytopenic purpura (cTTP). The genetically…

Read More

FDA Launches Pilot Program to Develop Rare Disease Therapies

A limited number of sponsors will be allowed to participate. The U.S. Food and Drug Administration (FDA) has launched the Support for clinical Trials Advancing Rare disease Therapeutics…

Read More

Healthcare Workers Union Coalition Strike Begins

Union negotiators say compensation proposals do not reflect the cost of living. A strike of more than 75,000 healthcare workers with the Coalition of Kaiser Permanente Unions began…

Read More

HHS Recommends Easing Marijuana Restrictions

Recommendation prompts the DEA to conduct a final review for reschedulization. The Department of Health and Human Services (HHS) has announced that the department recommends the reclassification of…

Read More

White House Advisor Certain of Legality of Drug Price Negotiations

Pharmaceutical companies challenge the administration in court over negotiations by Medicare. White House Domestic Policy Council Director Neera Tanden expressed confidence in the legality of Medicare’s new program…

Read More

Administration Announces Prescriptions Available for Price Negotiations

Ten drugs will be negotiated, with new pricing as of 2026. President Biden’s administration has announced the first 10 prescription drugs available for Medicare price negotiations. The pharmaceuticals…

Read More

Appeals Court Rules to Limit Access to Abortion Drug

Mifepristone was not ordered to be removed from the market, and the case goes to Supreme Court. The 5th Circuit Court of Appeals ruled that the Food and…

Read More

FDA and DEA Address Stimulant Medicine Shortage

Agency heads request an increase from manufacturers and for healthcare providers to slow demand. The Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) are taking steps…

Read More

Back to top
FE3